Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-01T04:10:36.660Z Has data issue: false hasContentIssue false
  • English
  • Français

Multidrug-Resistant Organism Colonization in a High-Risk Pediatric Patient Population

Published online by Cambridge University Press:  11 February 2016

Xiaoyan Song ,
Douglas Toal ,
Terry Walker ,
Evelio D. Perez-Albuerne ,
Joseph M. Campos  and
Roberta L. DeBiasi
Xiaoyan Song*
Affiliation:
Division of Pediatric Infectious Disease, Children’s National Medical Center, Washington, DC Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC
Douglas Toal
Affiliation:
OpGen, Gaithersburg, Maryland
Terry Walker
Affiliation:
OpGen, Gaithersburg, Maryland
Evelio D. Perez-Albuerne
Affiliation:
Division of Blood and Marrow Transplantation, Children’s National Medical Center, Washington, DC
Joseph M. Campos
Affiliation:
Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC Division of Laboratory Medicine, Children’s National Medical Center, Washington, DC Department of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
Roberta L. DeBiasi
Affiliation:
Division of Pediatric Infectious Disease, Children’s National Medical Center, Washington, DC Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC Department of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
*
Address correspondence to Xiaoyan Song, PhD, MBBS, George Washington University School of Medicine and Health Sciences, 111 Michigan Ave NW, Washington, DC 20010 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 5 , May 2016 , pp. 614 - 616
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Centers for Disease Control and Prevention (CDC). Laboratory detection of extended-spectrum β-lactamases (ESBLs). CDC website. http://www.cdc.gov/HAI/settings/lab/lab_esbl.html. Published November 2010. Accessed January 6, 2016.Google Scholar
2. Centers for Disease Control and Prevention (CDC). Multidrug-resistant organism & Clostridium difficile infection (MDRO/CDI) module. CDC website. http://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published January 2015. Modified April 2015. Accessed January 6, 2016.Google Scholar
3. Ford, CD, Lopansri, BK, Haydoura, S, et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol 2015;36:47–53.Google Scholar
4. Almyroudis, NG, Lesse, AJ, Hahn, T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011;32:490–496.Google Scholar
5. Vehreschild, MJ, Hamprecht, A, Peterson, L, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother 2014;69:3387–3392.CrossRefGoogle ScholarPubMed
6. Arnan, M, Gudiol, C, Calatayud, L, et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011;30:355–360.CrossRefGoogle ScholarPubMed
7. Centers for Disease Control and Prevention (CDC). Vital signs: marking healthcare safer: stop infections from lethal CRE infections now. CDC website. http://stacks.cdc.gov/view/cdc/13204. Published 2013. Accessed June 25, 2015.Google Scholar